Acute myeloid leukaemia trials in China

In China 226 Also abroad 763

226 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Where
Hangzhou
Age
18 years to 75 years
People
20
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07198867
Phase 1Taking people
A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Where
Beijing, Chengdu, Haerbin, Hefei, Jinan, Shanghai, Shenyang, Tianjin
Age
18 years to 75 years
People
130
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05924750
Phase 2Taking people
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
Where
Hangzhou
Age
18 years and over
People
72
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06621212
Phase 2Taking people
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
Where
Xiamen
Age
18 years and over
People
30
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT05305859
Phase 1Taking people
uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
Where
Tianjin
Age
18 years to 70 years
People
12
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07109518
Early phase 1Taking people
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
Where
Hangzhou
Age
18 years and over
People
50
Run by
Zhejiang University
See details and how to joinNCT07144020
Phase 1Taking people
A Study of GLB-001 in Patients With Myeloid Malignancies
Where
Beijing, Chongqing, Hangzhou, Hefei, Nanchang, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tianjin, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
108
Run by
Hangzhou GluBio Pharmaceutical Co., Ltd.
See details and how to joinNCT06378437
Early phase 1Taking people
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
Where
Beijing
Age
18 years and over
People
10
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07126782
Phase 3Taking people
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Where
Baoding, Beijing, Changchun, Changsha, Chengde, Chengdu, Chongqing, Fuzhou, Guangzhou, Guanzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Kunming, Luoyang, Nanchang, Nanjing, Nanning, Quanzhou, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Tianjin, Ürümqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Xuzhou, Yibin, Zhanjiang, Zhengzhou, Zunyi
Age
18 years and over
People
316
Run by
Hutchmed
See details and how to joinNCT06387069
No phaseTaking people
Venetoclax-Decitabine in Untreated Elderly/Unfit AML
Where
Hebei
Age
65 years and over
People
39
Run by
The Second Hospital of Hebei Medical University
See details and how to joinNCT07117422
Phase 3Taking people
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
Where
Changchun
Age
60 years to 75 years
People
68
Run by
Yehui Tan
See details and how to joinNCT06990321
Phase 2Taking people
Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
Where
Changchun
Age
18 years and over
People
70
Run by
Yehui Tan
See details and how to joinNCT07023588
Phase 2Taking people
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
Where
Taiyuan
Age
14 years to 65 years
People
50
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07108530
Phase 1Taking people
CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
Where
Tianjin
Age
18 years to 70 years
People
12
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07106749
No phaseTaking people
Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
Where
Tianjin
Age
18 years and over
People
184
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06386302
No phaseTaking people
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Where
Shanghai
Age
18 years to 65 years
People
50
Run by
Ruijin Hospital
See details and how to joinNCT06458257
Phase 2Not yet taking people in China
Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
Where
Shanghai
Age
14 years to 70 years
People
44
Run by
Ruijin Hospital
See details and how to joinNCT07091006
No phaseNot yet taking people in China
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
Where
Shanghai
Age
18 years and over
People
18
Run by
Ruijin Hospital
See details and how to joinNCT07087847
Phase 2Taking people
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
Where
Shanghai
Age
18 years to 65 years
People
48
Run by
Ruijin Hospital
See details and how to joinNCT07028086
Phase 1/2Taking people
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
Where
Suzhou
Age
2 years to 65 years
People
20
Run by
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT07036250
Phase 1/2Taking people
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
Where
Suzhou
Age
18 years and over
People
78
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07028073
Phase 2Taking people
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
Where
Suzhou
Age
14 years and over
People
32
Run by
yuejun Liu
See details and how to joinNCT07012447
Phase 2Taking people
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
Where
Suzhou
Age
18 years and over
People
42
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07007949
Phase 1Taking people
A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Where
Tianjin
Age
18 years to 70 years
People
37
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06880354
Phase 1/2Enrolling by invitation
Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
Where
Tianjin
Age
14 years to 55 years
People
80
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT03031249